Method for delivering fc fusion molecule

TW202641852APending Publication Date: 2026-10-16VIRIDIAN THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143913
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-17
Filing Date
2025-11-11
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080599_001
    Figure TWG2TA001080599_001
  • Figure TWG2TA001080599_002
    Figure TWG2TA001080599_002
  • Figure TWG2TA001080599_003
    Figure TWG2TA001080599_003
Patent Text Reader

Abstract

The present invention provides, among other things, a method of treating a disease or disorder comprising administering an Fc fusion molecule that binds neonatal Fc receptor (FcRn) at a therapeutically effective dosing regimen, wherein the Fc fusion molecule comprises a modified Fc region, a linker and an albumin or an albumin binding domain.
Need to check novelty before this filing date? Find Prior Art